208 related articles for article (PubMed ID: 24360654)
1. Fluorescence in situ hybridization for diagnosis of cholangiocarcinoma in primary sclerosing cholangitis: a systematic review and meta-analysis.
Navaneethan U; Njei B; Venkatesh PG; Vargo JJ; Parsi MA
Gastrointest Endosc; 2014 Jun; 79(6):943-950.e3. PubMed ID: 24360654
[TBL] [Abstract][Full Text] [Related]
2. Diagnostic yield of bile duct brushings for cholangiocarcinoma in primary sclerosing cholangitis: a systematic review and meta-analysis.
Trikudanathan G; Navaneethan U; Njei B; Vargo JJ; Parsi MA
Gastrointest Endosc; 2014 May; 79(5):783-9. PubMed ID: 24140129
[TBL] [Abstract][Full Text] [Related]
3. Primary sclerosing cholangitis patients with serial polysomy fluorescence in situ hybridization results are at increased risk of cholangiocarcinoma.
Barr Fritcher EG; Kipp BR; Voss JS; Clayton AC; Lindor KD; Halling KC; Gores GJ
Am J Gastroenterol; 2011 Nov; 106(11):2023-8. PubMed ID: 21844920
[TBL] [Abstract][Full Text] [Related]
4. Clinical implications of serial versus isolated biliary fluorescence in situ hybridization (FISH) polysomy in primary sclerosing cholangitis.
Quinn KP; Tabibian JH; Lindor KD
Scand J Gastroenterol; 2017 Apr; 52(4):377-381. PubMed ID: 27908204
[TBL] [Abstract][Full Text] [Related]
5. Systematic review with meta-analysis: endoscopic retrograde cholangiopancreatography-based modalities for the diagnosis of cholangiocarcinoma in primary sclerosing cholangitis.
Njei B; McCarty TR; Varadarajulu S; Navaneethan U
Aliment Pharmacol Ther; 2016 Dec; 44(11-12):1139-1151. PubMed ID: 27696456
[TBL] [Abstract][Full Text] [Related]
6. Differential diagnosis of cholangiocarcinoma and IgG4-related sclerosing cholangitis by fluorescence in situ hybridization using transpapillary forceps biopsy specimens.
Kato A; Naitoh I; Miyabe K; Hayashi K; Kondo H; Yoshida M; Kato H; Kuno T; Takahashi S; Joh T
J Hepatobiliary Pancreat Sci; 2018 Mar; 25(3):188-194. PubMed ID: 29532638
[TBL] [Abstract][Full Text] [Related]
7. Screening and diagnosis of cholangiocarcinoma in patients with primary sclerosing cholangitis.
Jesudian AB; Jacobson IM
Rev Gastroenterol Disord; 2009; 9(2):E41-7. PubMed ID: 19668124
[TBL] [Abstract][Full Text] [Related]
8. Long-term outcomes of positive fluorescence in situ hybridization tests in primary sclerosing cholangitis.
Bangarulingam SY; Bjornsson E; Enders F; Barr Fritcher EG; Gores G; Halling KC; Lindor KD
Hepatology; 2010 Jan; 51(1):174-80. PubMed ID: 19877179
[TBL] [Abstract][Full Text] [Related]
9. Recall processes for biliary cytology in primary sclerosing cholangitis.
Eaton JE; Gossard AA; Talwalkar JA
Curr Opin Gastroenterol; 2014 May; 30(3):287-94. PubMed ID: 24686433
[TBL] [Abstract][Full Text] [Related]
10. Polysomy and p16 deletion by fluorescence in situ hybridization in the diagnosis of indeterminate biliary strictures.
Gonda TA; Glick MP; Sethi A; Poneros JM; Palmas W; Iqbal S; Gonzalez S; Nandula SV; Emond JC; Brown RS; Murty VV; Stevens PD
Gastrointest Endosc; 2012 Jan; 75(1):74-9. PubMed ID: 22100297
[TBL] [Abstract][Full Text] [Related]
11. Biliary multifocal chromosomal polysomy and cholangiocarcinoma in primary sclerosing cholangitis.
Eaton JE; Barr Fritcher EG; Gores GJ; Atkinson EJ; Tabibian JH; Topazian MD; Gossard AA; Halling KC; Kipp BR; Lazaridis KN
Am J Gastroenterol; 2015 Feb; 110(2):299-309. PubMed ID: 25623660
[TBL] [Abstract][Full Text] [Related]
12. Cost utility of ERCP-based modalities for the diagnosis of cholangiocarcinoma in primary sclerosing cholangitis.
Njei B; McCarty TR; Varadarajulu S; Navaneethan U
Gastrointest Endosc; 2017 Apr; 85(4):773-781.e10. PubMed ID: 27590963
[TBL] [Abstract][Full Text] [Related]
13. The Detection of Cholangiocarcinoma in Primary Sclerosing Cholangitis Patients: Single Center Experience.
Kuzu UB; Ödemiş B; Suna N; Yıldız H; Parlak E; Dişibeyaz S; Torun S; Akpınar MY; Coşkun O; Turhan N; Yüksel M; Kayaçetin E
J Gastrointest Cancer; 2016 Mar; 47(1):8-14. PubMed ID: 26537791
[TBL] [Abstract][Full Text] [Related]
14. "FISHing" for an accurate diagnostic test for cholangiocarcinoma.
Koro NS; Elmunzer BJ; Coté GA
Gastroenterology; 2015 Mar; 148(3):655-7. PubMed ID: 25625763
[No Abstract] [Full Text] [Related]
15. Volatile organic compounds in bile for early diagnosis of cholangiocarcinoma in patients with primary sclerosing cholangitis: a pilot study.
Navaneethan U; Parsi MA; Lourdusamy V; Bhatt A; Gutierrez NG; Grove D; Sanaka MR; Hammel JP; Stevens T; Vargo JJ; Dweik RA
Gastrointest Endosc; 2015 Apr; 81(4):943-9.e1. PubMed ID: 25500329
[TBL] [Abstract][Full Text] [Related]
16. Diagnostic performance of a stepwise cytological algorithm for biliary malignancy in primary sclerosing cholangitis.
von Seth E; Ouchterlony H; Dobra K; Hjerpe A; Arnelo U; Haas S; Bergquist A
Liver Int; 2019 Feb; 39(2):382-388. PubMed ID: 30507030
[TBL] [Abstract][Full Text] [Related]
17. Cholangiocarcinoma in patients with primary sclerosing cholangitis: a multicenter case-control study.
Chalasani N; Baluyut A; Ismail A; Zaman A; Sood G; Ghalib R; McCashland TM; Reddy KR; Zervos X; Anbari MA; Hoen H
Hepatology; 2000 Jan; 31(1):7-11. PubMed ID: 10613720
[TBL] [Abstract][Full Text] [Related]
18. Biliary dysplasia in primary sclerosing cholangitis harbors cytogenetic abnormalities similar to cholangiocarcinoma.
Kerr SE; Barr Fritcher EG; Campion MB; Voss JS; Kipp BR; Halling KC; Lewis JT
Hum Pathol; 2014 Sep; 45(9):1797-804. PubMed ID: 25027853
[TBL] [Abstract][Full Text] [Related]
19. Diagnosing cholangiocarcinoma in primary sclerosing cholangitis: an "evidence based radiology" review.
Walker SL; McCormick PA
Abdom Imaging; 2008; 33(1):14-7. PubMed ID: 17874262
[TBL] [Abstract][Full Text] [Related]
20. Optimizing the detection of biliary dysplasia in primary sclerosing cholangitis before liver transplantation.
Majeed A; Castedal M; Arnelo U; Söderdahl G; Bergquist A; Said K
Scand J Gastroenterol; 2018 Jan; 53(1):56-63. PubMed ID: 28990806
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
